Skip to main content
Domainex
  • About
    • About
    • Track Record
    • Case Studies
    • Testimonials
    • Awards & Accreditations
    • Our team
    • Board members
    • Investors
    • Contact us
  • Solutions
    • Services
      • Biosciences
        • ADME and Bioanalytical Sciences
        • Assay Development and Transfer
        • Biochemistry / Enzymology
        • Biophysics
        • Cellular Biology
        • Compound screening and cascade design
        • Cryo-EM
        • Project Management and Consultancy Services
        • Protein Expression
        • Structural Biology
        • X-ray Crystallography
      • Chemistry
        • Analytical Chemistry
        • Direct-to-Biology (D2B)
        • Medicinal Chemistry
        • Synthetic Chemistry
      • Integrated Drug Discovery
        • Fragment based drug discovery
        • Lead Discovery
        • Hit to Lead
        • Hit Identification
        • Lead Optimisation
        • Project Management and Consultancy Services
        • Structure Based Drug Design (SBDD)
      • Computer Aided Drug Design
        • Computational Chemistry and Biology
        • Virtual Screening
      • Hit Identification
        • Fragment Screening
        • High Throughput Screening
        • Virtual Screening
    • Target Classes and Modalities
      • Biotherapeutics
      • Covalent Inhibitors
      • GPCRs
      • Ion Channels
      • Kinases
      • Methyltransferases
      • Molecular Glues
      • Prodrugs
      • Proteases
      • Protein-Protein Interactions
      • Targeted Protein Degradation
    • Therapeutic Areas
      • Anti-infectives
      • Cardiovascular
      • CNS
      • Immuno-Oncology
      • Inflammatory diseases
      • Oncology
      • Respiratory
    • A-Z
      • A
        • Aldehyde Oxidase Stability Assay
        • Analytical Chemistry
        • Anti-infectives
        • Assay Development and Transfer
      • B
        • Biochemistry / Enzymology
        • Biophysics
        • Biotherapeutics
      • C
        • CDH (Target Gene Fragmentation)
        • CNS
        • Caco-2 Permeability Assay
        • Cardiovascular
        • Cellular Biology
        • Compound screening and cascade design
        • Computational Chemistry and Biology
        • Covalent Inhibitors
        • Cryo-EM
      • D
        • Differential Scanning Fluorimetry (DSF) and nanoDSF Services
        • Direct-to-Biology (D2B)
        • Dynamic Light Scattering (DLS)
      • E
        • Experimental Polar Surface Area (EPSA) Assay
      • F
        • Flow Cytometry
        • Fragment based drug discovery
      • G
        • GPCRs
        • GSH Reactivity Assay
      • H
        • Hepatocyte Clearance/Stability Assay
        • High Throughput Screening
        • Hit Identification
        • Hit to Lead
      • I
        • Immuno-Oncology
        • Inflammatory diseases
        • Innovative Polymer Lipid Particle (PoLiPa) Technology
        • Integrated Drug Discovery
        • Ion Channels
        • Isothermal Titration Calorimetry (ITC)
      • K
        • Kinact / KI Assay for Irreversible Covalent Compounds
        • Kinases
      • L
        • Lead Optimisation
        • Ligand binding assays by Surface Plasmon Resonance (SPR) and/or Grating-Coupled Interferometry (GCI)
      • M
        • Medicinal Chemistry
        • Membrane protein production
        • Methyltransferases
        • Microsomal Clearance/Stability Assay
        • Molecular Glues
      • N
        • Neuroinflammation
      • O
        • Oncology
      • P
        • Photoaffinity Labelling
        • Plasma Protein Binding Assay
        • Plasma Stability Assay
        • Project Management and Consultancy Services
        • Proteases
        • Protein Expression
        • Protein-Protein Interactions
      • R
        • Respiratory
        • Reversible Covalent Inhibitor Binding Assay
      • S
        • Shake Flask LogD
        • Spectral Shift and MST Services
        • Structural Biology
        • Structure Based Drug Design (SBDD)
        • Synthetic Chemistry
      • T
        • Targeted Protein Degradation
        • Targeted Protein Degrader Toolbox
        • Ternary Complex Formation Assays
        • Thermodynamic Solubility Assay
        • Turbidimetric (Kinetic) Solubility Assay
      • V
        • Virtual Screening
      • X
        • X-ray Crystallography
  • Library
    • Articles
    • Brochures
    • Newsletters
    • Posters
    • Presentations & Videos
    • Publications
    • White Papers
    • Webinars
  • News & Events
  • Careers
  • English
  • French
  • Spanish
  • German
  • Italian
  • Japanese
  • Dutch
  • USA
Enquire

Case Studies

Delivering innovative science

Our highly experienced and expert scientific team has an unrivalled track record of solving research challenges, delivering successful outcomes efficiently, and therefore setting the highest possible benchmark in medicines research.

CDH Case Studies

Case studies using our patented combinatorial domain hunting (CDH) technology, which has been applied to over 60 targets in a wide range of target classes.
View more

Neurotensin Receptor 1: Purification by PoLiPa

We used the neurotensin receptor 1 (NTSR1) as a proof-of-concept study to demonstrate the effectiveness of our PoLiPa GPCR purification process.
View more

CD73: A structural biology case study

Domainex established biochemical and ligand-binding assays for CD73 and the expressed protein was also used successfully in X-ray crystallography studies.
View more

Gram-Negative Antibiotics: A Drug Discovery Case Study

Domainex helped develop a novel class of gold(I) antibiotic, with broad spectrum antibacterial activity against the ESKAPE pathogens.
View more

Confirmation of THP1 cell differentiation by flow cytometry

View more

PBMC population identification using flow cytometry

View more

Flow cytometry apoptosis assay in Jurkat cells

View more

Spectral Shift Competition Assay: A robust and versatile assay to assess compound binding to a panel of kinases

View more

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2

Start your next project with Domainex

Contact one of our experts today
Domainex

+44(0) 1223 433180 enquiries@domainex.co.uk

Cyber Essentials - Certified Plus

Domainex is a registered company (number 4336899)

Site and its contents Copyright © Domainex 2025. All rights reserved.

Terms and Conditions | Privacy Policy